Cargando…

Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons Learned

INTRODUCTION: Observational data suggest that B-cell-depleting therapies are effective for antibody-mediated autoimmune encephalitis. However, randomized controlled trials are needed. Here, we report challenges encountered in a randomized, placebo-controlled trial of ocrelizumab for autoimmune encep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blackburn, Kyle M., Denney, David A., Hopkins, Steven C., Vernino, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095811/ https://www.ncbi.nlm.nih.gov/pubmed/35129803 http://dx.doi.org/10.1007/s40120-022-00327-x

Ejemplares similares

Antibody Testing for Neurological Autoimmune Disorders: Evaluation of Best Practices at a Tertiary Referral Center
por: Fredrich, Sarah E., et al.
Publicado: (2021)

Autoimmune Encephalitis Misdiagnosis in Adults
por: Flanagan, Eoin P., et al.
Publicado: (2022)

Refractory Anti-NMDA Receptor Encephalitis in Early Pregnancy: A Case Report of Treatment Course and Pregnancy Outcomes
por: Fredrich, Sarah, et al.
Publicado: (2022)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Viral pericarditis following ocrelizumab in a multiple sclerosis patient
por: Miele, Giuseppina, et al.
Publicado: (2023)

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
por: Marrinan, Sarah L., et al.
Publicado: (2017)

Transient neonatal autoimmune autonomic ganglionopathy
por: Baker, Steven K., et al.
Publicado: (2014)

Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
por: Habibi, Amir Hassan, et al.
Publicado: (2018)

Extensive Recruitment of Plasma Blasts to the Cerebrospinal Fluid in Toscana Virus Encephalitis
por: Schirmer, Lucas, et al.
Publicado: (2015)

Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial
por: Bermel, Robert A., et al.
Publicado: (2021)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Dilemmas and Challenges in Treating Seronegative Autoimmune Encephalitis in Indian Children
por: Sahoo, Bandya, et al.
Publicado: (2018)

Hyperventilation‐induced focal seizures in adults: think autoimmune encephalitis
por: Wennberg, Richard A.
Publicado: (2022)

Evaluation of levetiracetam as a pre-operative anxiolytic: A randomized, double-blind, placebo-controlled study
por: Choupoo, Nang Sujali, et al.
Publicado: (2015)

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
por: Yoritaka, Asako, et al.
Publicado: (2021)

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
por: Gibson, Elena G, et al.
Publicado: (2021)

Association of STAT6 gene variants with food allergy diagnosed by double‐blind placebo‐controlled food challenges
por: van Ginkel, C. D., et al.
Publicado: (2018)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
por: Emery, Paul, et al.
Publicado: (2014)

Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
por: Abboud, Hesham, et al.
Publicado: (2021)

Autoimmune Encephalitis Presenting as Dystonia-Parkinsonism
por: Milburn, Sophia E., et al.
Publicado: (2022)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis
por: van Kempen, Zoé L. E., et al.
Publicado: (2022)

Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study
por: Peterson, Christine T., et al.
Publicado: (2018)

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
por: Hartung, H-P, et al.
Publicado: (2020)

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
por: Abboud, Hesham, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Brill, Livnat, et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
por: Mohammed, Shaadab, et al.
Publicado: (2021)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
por: Rahman, Farah, et al.
Publicado: (2022)

Ocrelizumab-Induced Severe Colitis
por: Lee, Hsing Hwa, et al.
Publicado: (2020)

Autoimmune encephalitis associated with autoimmune blistering diseases: A case series and retrospective review
por: Tadros, Andrew R., et al.
Publicado: (2023)

Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study
por: Seitsalo, Hubertus, et al.
Publicado: (2007)

A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of 1-Kestose on Defecation Habits in Constipated Kindergarten Children: A Pilot Study
por: Takahashi, Mayuko, et al.
Publicado: (2023)

Autoimmune encephalitis
por: Joob, Beuy, et al.
Publicado: (2016)

COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series
por: Hughes, Richard, et al.
Publicado: (2020)

Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune Hepatitis
por: O’Brien, Christopher B., et al.
Publicado: (2018)

Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double‐Blinded, Placebo‐Controlled CITRIS‐AF Pilot Study
por: Trankle, Cory R., et al.
Publicado: (2020)

COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
por: Jaber, Aliya, et al.
Publicado: (2023)

A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
por: Nguyen, Nguyet Minh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ck2df1esc267bct9jdc89q28cb